0RQO.LSE BoneSupport Holding AB

Healthcare Commercial Services & Supplies London Exchange
- SEK
Market cap
-
P/E
-
P/B
-
ROE
30.6%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 0RQO.LSE undervalued?

Graham number

The Graham number of BoneSupport Holding AB cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

BoneSupport Holding AB fundamental analysis

No fundamental analysis for BoneSupport Holding AB yet.

BoneSupport Holding AB stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About BoneSupport Holding AB

Bonesupport Holding AB (publ), an orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally. The company offers CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and …

Full company profile